000			02914nas a22002895i 4500
001			1573-7217
003			DE-He213
005			20200203195213.0
007			cr nn 008mamaa
008			150723s||||||||xxuuu poo|||||| b|EN |d
022			_a1573-7217
024	7		_a10.1007/10549.1573-7217 _2doi
210	1	0	_aBreast Cancer Res Treat
245	1	0	_aBreast Cancer Research and Treatment _h[electronic resource] / _cedited by William J. Gradishar.
264		1	_aNew York : _bSpringer US : _bImprint: Springer.
300			_bonline resource.
520			_aBreast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer. Oncology is undoubtedly one of the largest subspecialties in the field of medicine, and breast cancer is one of the most serious problems. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Breast Cancer Research and Treatment is an international arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics. There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.
650		0	_aOncology.
650	1	4	_aOncology. _0http://scigraph.springernature.com/things/product-market-codes/H33160
700	1		_aGradishar, William J. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x0167-6806
856	4	0	_uhttps://doi.org/10.1007/10549.1573-7217 _zHybrid
999			_c457518 _d457518
942			_cEMG